BLOOD matters - Société Canadienne de l'Hémophilie
BLOOD matters - Société Canadienne de l'Hémophilie
BLOOD matters - Société Canadienne de l'Hémophilie
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Hemophilia Ontario<br />
World Congress in Buenos Aires<br />
by Cameron Peters<br />
Photo credit: Mike Beck<br />
Cameron Peters, Candy Terpstra and Mike<br />
Beck at the World Congress in Buenos Aires,<br />
Argentina<br />
12\ Blood Matters Fall 2010<br />
I atten<strong>de</strong>d the 2010 Hemophilia World Congress in Buenos Aires in<br />
July, 2010 as a youth recipient of the Karttik Shah fellowship. Through my<br />
experiences at Congress, I learned a number of things that I will be able to<br />
use in my work with Hemophilia Ontario. First, I engaged with the broa<strong>de</strong>r<br />
hemophilia community in Canada. Having not atten<strong>de</strong>d a national or international<br />
event before, the congress allowed me to meet with lea<strong>de</strong>rs in<br />
our community from across the country and to share experiences and i<strong>de</strong>as<br />
on how to meet the needs of our membership. This, in turn, has led me to<br />
new ways of viewing issues in my work in Ontario. I un<strong>de</strong>rstand better how<br />
research is done in Canada and how the Canadian Hemophilia Society and<br />
its provincial chapters interact with health professionals across the country.<br />
These important aspects of our organization could only have been learned<br />
through attending the Congress.<br />
Second, the Congress was an excellent opportunity to learn about the<br />
latest advancements in areas that relate to my particular health challenges.<br />
Experts on Hepatitis C provi<strong>de</strong>d an update on the future of treatments. In<br />
particular, protease inhibitors, projected to be available in the next few years,<br />
are expected to significantly improve treatment outcomes, especially for<br />
those affected by Genotype I Hepatitis C. Physiotherapists presented studies<br />
on total joint replacement of ankles, which is still consi<strong>de</strong>red to be a rather<br />
novel therapy as ankle fusion remains the preference for many treatment<br />
centres in the <strong>de</strong>veloped world.<br />
Third, I was able to meet other youth <strong>de</strong>legates and share experiences<br />
with them about our health difficulties. There were dozens of youth <strong>de</strong>legates<br />
from all over the world at the conference, and meeting them provi<strong>de</strong>d a different<br />
perspective on how their NMOs work to help individuals affected by<br />
bleeding disor<strong>de</strong>rs. For example, I spoke with a youth <strong>de</strong>legate from Latvia,<br />
who is currently involved with her NMO in helping hemophiliacs with court<br />
cases where they are taking the government to court over its <strong>de</strong>cision to<br />
restrict funding for treatment. Also, I spoke with many youth from Tunisia,